Friday Foolery #48 Brilliant Library Notices

13 01 2012

Today’s Friday Foolery post is handed on a silver platter by my Australian friend Mike Cadogan @sandnsurf from Life in the Fast Lane

Yes, aren’t these brilliant librarian notices from the Milwaukee Public Library?!

Note:

@Bitethedust, also from Australian rightly noticed: there’s no better place to stick @sandnsurf than in Friday foolery

Indeed at Life at the Fast Lane they have fun posts amidst the serious (mostly ER) topics. Want more Friday Fun than have a look at the Funtabulously Frivolous Friday Five Posts.





“Pharmacological Action” in PubMed has no True Equivalent in OVID MEDLINE

11 01 2012

Searching for EMBASE Subject Headings (the EMBASE index terms) for drugs is relatively straight forward in EMBASE.

When you want to search for aromatase inhibitors you first search for the Subject Heading mapping to aromatase inhibitors (aromatase inhibitor). Next you explode aromatase inhibitor/ if you are interested in all its narrower terms. If not, you search both for the general term aromatase inhibitor and those specific narrower terms you want to include.
Exploding aromatase inhibitor (exp aromatase inhibitor/) yields 15938 results. That is approximately twice what you get by searching aromatase inhibitor/ alone (not exploded). This yields 7434 hits.

It is different in MEDLINE. If you search for aromatase inhibitors in the MeSH database you get two suggestions.

The first index term “Aromatase Inhibitors” is a Mesh. It has no narrower terms.
Drug-Mesh are generally not arranged by working mechanism, but by chemical structure/type of compound. That is often confusing. Spironolactone for instance belongs to the MeSH Lactones (and Pregnenes) not to the MeSH Aldosterone Antagonists or Androgen Antagonist. Most Clinicians want to search for a group of compounds with the same mechanism of action, not the same biochemical family

The second term “Aromatase Inhibitors” [Pharmacological Action]  however does stand for the working mechanism. It does have narrower terms, including 2 MeSH terms (highlighted) and various substance names, also called Supplementary Concepts. 

For complete results you have to search for both MeSH and Pharmacological action: “Aromatase Inhibitors”[Mesh] yields 3930 records, whereas (“Aromatase Inhibitors”[Mesh]) OR “Aromatase Inhibitors” [Pharmacological Action] yields 6045. That is a lot more.

I usually don’t search PubMed, but OVID MEDLINE.

I know that Pharmacological Action-subheadings are important, so I tried to find the equivalent in OVID .

I found the MeSH Aromatase Inhibitors, but -unlike PubMed- OVID showed only two narrower Drug Terms (called Non-MeSH here versus MeSH in PubMed).

I found that odd.

I reasoned “Pharmacological action” might perhaps be combined with the MESH in OVID MEDLINE. This was later confirmed by Melissa Rethlefsen (see Twitter discussion below)

In Ovid MEDLINE I got 3937 hits with Aromatase Inhibitors/ and 5219 with exp Aromatase Inhibitors/ (thus including aminogluthemide or Fadrozole)

At this point I checked PubMed (shown above). Here I found  that “Aromatase Inhibitors”[Mesh] OR “Aromatase Inhibitors” [Pharmacological Action] yielded 6045 hits in PubMed, against 5219 in OVID MEDLINE for exp Aromatase Inhibitors/

The specific aromatase inhibitors Aminogluthemide/and Fadrozole/ [set 60] accounted fully for the difference  between exploded [set 59] and non-exploded Aromatase Inhibitors[set 58].

But what explained the gap of approximately 800 records between “Aromatase Inhibitors”[Mesh] OR “Aromatase Inhibitors”[Pharmacological Action]* in PubMed and exp aromatase inhibitors/ in OVID MEDLINE?

Could it be the substance names, mentioned under “Aromatase Inhibitors”[Pharmacological Action], I wondered?

Thus I added all the individual substance names in OVID MEDLINE (code= .rn.). See search set 61 below.

Indeed these accounted fully for the difference (set 62= 59 or 61 : the total number of hits in PubMed is similar)

It obviously is a mistake of OVID MEDLINE and I will inform them.

For the meanwhile, take care to add the individual substance names when you search for drug terms that have a pharmacological action-equivalent in PubMed. The substance names are not automatically searched when exploding the MeSH-term in OVID MEDLINE.

——–

For more info on Pharmacological action, see: http://www.nlm.nih.gov/bsd/disted/mesh/paterms.html

Twitter Discussion between me and Melissa Rethlefsen about the discrepancy between PubMed and OVID MEDLINE (again showing how helpful Twitter can be for immediate discussions and exchange of thoughts)

[read from bottom to top]





Grand Rounds: Evolving from Link-♥♥ to ♬♫-Links?

9 01 2012

Grand Rounds is “the weekly summary of the best healthcare writing online”. I’ve hosted this medical blog carnival twice and considered it a great honor to do so.

I have submitted a lot of posts to the Grand Rounds. Often I even wrote a special blog post to fit the theme if there was one. Almost all my submissions have been accepted. I really enjoyed the compilations. There was a lot of outstanding creativity and originality in how the links to the blogs were “aggregated” and highlighted.

Usually I only read those posts that seemed the most interesting to me (the summary thus works as a filter). But through the Grand Rounds I read posts that I would never have read and I learned about bloggers I never heard of.

Why am I talking in the past tense? The Grand Round is still there, isn’t it?!

Yes, it is still there (luckily), but the organizers are thinking of a “rejuvenation of  this old dinosaur”. As the previous host, Margaret Polaneczky explained

“… Grand Rounds has dropped a bit off all of our radars. Many, if not most of us have abandoned the old RSS feed to hang out on Twitter, where our online community has grown from a few dozen bloggers to feeds and followers in the hundreds and even thousands.”

One of the measures is that the Grand Rounds editions should be more concise and only include the “best posts”.

I too go for quality, and think one should carefully select contributors (and hosts), but is the 7-year-old dinosaur to be saved by chopping him in pieces? Should we only refer to 10 posts at the max and put the message in a tweet-format like Margaret did in an experiment?
I was glad that Margaret gave a good old fashioned long introduction in the Dinosaur’s style, for that was what I read, NOT the tweets. Sorry tweets are NOT a nice compilation. They are difficult to read.
It also isn’t a solution to tweet the individual links, because a lot of those individual tweets will be missed by most of the potential readers. It is not coherent either. The strength of the Grand Rounds is in the compilation, in the way the host makes the posts digestible. I would say: let the host present the posts in an attractive way and let the reader do the selection and digestion.

Also important: how many of us will write blog posts specially for the Grand Rounds if there is a chance of 2 in 3 that it will be rejected?

It is true that the Grand Rounds is less popular than a few years ago and it is harder to get hosts. But that may partly have to do with advertising. My first Grand Rounds got far more hits than the second one, mainly because we sent a notice to great blogs that linked to us, like Instapundit (853 hits alone) and there was an interview with the host announcing the Grand Rounds at MEDSCAPE. In this way the main intended audience (non-blogging lay people) were also reached. The second time my post was just found by a handful of people checking the edition plus this blog own readers.
(I have to admit that this last Grand Rounds Edition might have been better if it had been more concise, but at least one person (Pranab of Scepticemia) spend  2 hours in reading almost all the posts of the round-up. So it wasn’t for nothing)

If some busy clinicians can be persuaded to host The Grand Rounds using a shorter format, that is fine. And it is good to be more concise and leave out what isn’t of high quality. But why make it a rule to include just 10 or 12? Even more important, don’t change blog posts for tweets. For I don’t think, as Margaret passed on, that the concept of the individual blog has been sometimes “overshadowed by Twitter and Facebook, whose continual unending stream demands our constant attention, lest we miss something important that someone said or re-said…” Even I have given up to constantly follow all streams, and I suppose the same is true for most clinicians, nurses etc. Lets not replace posts by tweets but lets use Twitter and Facebook to promote the Grand Rounds and augment its radius.

The main reason for writing this post is that I disliked the description by Bryan Vartebedian (host of the next round) rather off-putting, perhaps even arrogant:

Grand Rounds is evolving as a more focused, curated publication.  Rather than a 4,000 word chain-o-links, Nick Genes, Val Jones and others felt that a focused collection of recommendations would be more manageable for both readers and hosts.  This is Grand Rounds for quality rather than link love.

Bryan loves the word link-love. Two posts back he wrote:

It isn’t contacts, followers, friends, subscriptions, readers, link love, mentions, or people’s attention.  It’s time.  With time I can have all of these things.  

“Link love” and “chain-o-links” undervalue what blog carnivals are about. Perhaps some bloggers just want to be linked to, but most want to be read, and that is the entire idea behind the blog carnival. I can’t imagine that the blog hosts aim to include as many links as possible. At the most it is love for particular posts not “link love” perse.

Changing the format to tweets (♬♫) will only increase the link/text ratio. Links will become more prominent.

I would rather go for the ♥♥-links*, because I  to blog and I  to read good stuff.

——–

* Note that ♥♥-links is not the same as link-♥

——–

Here is a short Twitter Discussion about the new approach. I fully agree with Ves Dimov viewpoint, especially the last tweet.





Friday Foolery # 47 WTF, the True Spirit of Christmas

30 12 2011

The true spirit of Christmas is in “loving” and to “do good for others”, “ thinking of” and “helping the less fortunate”.

However, many of today’s children,  weaned on luxury goods and gadgets, consider themselves as the “less fortunates” and thus are on the  ”receiving” rather than the “giving” site. And are easily disappointed… and crossed if they don’t get the expected $$$ gift.

Am I exaggerating? I truly hope so.

But if you had searched Twitter for popular expensive gits “car”, “i-pad” or “i-phone” like comedy writer Jon Hendren (@fart) did, you had seen numerous dissatisfied tweets of extremely spoiled kids and adolescents:

http://twitter.com/SeanMcmaster1/status/151044946164584448

———–

The tweets have even been compiled in a song by Jonathan Mann, the “Song a Day Man“. After seeing the tweets it should be no surprise that it is called “WTF?! I wanted an iPhone!”

———–

It makes me kind a sad. It is quite an anti-Christmas attitude.

The kids in this video below have every right to be disappointed though. (via Mashable)

———–

Sources





Friday Foolery #46 Bad Science: The Psychology Behind Exaggerated & False Results

23 12 2011

Very up-to-date infographic about Bad Science: it includes (or was inspired by?) the recent fraud by Diederik Stapel, a well-known psychologist in the Netherlands.(e.g. see NY Times.com (2011/11/03/).

I am not sure though, that I agree with the 3rd solution to make research more honest: anonymous publication.

Bad Science
Created by: Clinical Psychology

Hattip: @nutrigenomics@Vansteenwinckel@kitteybeth & @rawarrior via Twitter





Jeffrey Beall’s List of Predatory, Open-Access Publishers, 2012 Edition

19 12 2011

Perhaps you remember that I previously wrote [1] about  non-existing and/or low quality scammy open access journals. I specifically wrote about Medical Science Journals of  the http://www.sciencejournals.cc/ series, which comprises 45 titles, none of which having published any article yet.

Another blogger, David M [2] also had negative experiences with fake peer review invitations from sciencejournals. He even noticed plagiarism.

Later I occasionally found other posts about open access spam, like the post of Per Ola Kristensson [3] (specifically about Bentham, Hindawi and InTech OA publishers), of Peter Murray-Rust [4] ,a chemist interested in OA (about spam journals and conferences, specifically about Scientific Research Publishing) and of Alan Dove PhD [5] (specifically about The Journal of Computational Biology and Bioinformatics Research (JCBBR) published by Academic Journals).

But now it appears that there is an entire list of “Predatory, Open-Access Publishers”. This list was created by Jeffrey Beall, academic librarian at the University of Colorado Denver. He just updated the list for 2012 here (PDF-format).

According to Jeffrey predatory, open-access publishers

are those that unprofessionally exploit the author-pays model of open-access publishing (Gold OA) for their own profit. Typically, these publishers spam professional email lists, broadly soliciting article submissions for the clear purpose of gaining additional income. Operating essentially as vanity presses, these publishers typically have a low article acceptance threshold, with a false-front or non-existent peer review process. Unlike professional publishing operations, whether subscription-based or ethically-sound open access, these predatory publishers add little value to scholarship, pay little attention to digital preservation, and operate using fly-by-night, unsustainable business models.

Jeffrey recommends not to do business with the following (illegitimate) publishers, including submitting article manuscripts, serving on editorial boards, buying advertising, etc. According to Jeffrey, “there are numerous traditional, legitimate journals that will publish your quality work for free, including many legitimate, open-access publishers”.

(For sake of conciseness, I only describe the main characteristics, not always using the same wording; please see the entire list for the full descriptions.)

Watchlist: Publishers, that may show some characteristics of  predatory, open-access publisher
  • Hindawi Way too many journals than can be properly handled by one publisher
  • MedKnow Publications vague business model. It charges for the PDF version
  • PAGEPress many dead links, a prominent link to PayPal
  • Versita Open paid subscription for print form. ..unclear business model

An asterisk (*) indicates that the publisher is appearing on this list for the first time.

How complete and reliable is this list?

Clearly, this list is quite exhaustive. Jeffrey did a great job listing  many dodgy OA journals. We should watch (many) of these OA publishers with caution. Another good thing is that the list is updated annually.

(http://www.sciencejournals.cc/ described in my previous post is not (yet) on the list ;)  but I will inform Jeffrey).

Personally, I would have preferred a distinction between real bogus or spammy journals and journals that seem to have “too many journals to properly handle” or that ask (too much ) money for subscription/from the author. The scientific content may still be good (enough).

Furthermore, I would rather see a neutral description of what is exactly wrong about a journal. Especially because “Beall’s list” is a list and not a blog post (or is it?). Sometimes the description doesn’t convince me that the journal is really bogus or predatory.

Examples of subjective portrayals:

  • Dove Press:  This New Zealand-based medical publisher boasts high-quality appearing journals and articles, yet it demands a very high author fee for publishing articles. Its fleet of journals is large, bringing into question how it can properly fulfill its promise to quickly deliver an acceptance decision on submitted articles.
  • Libertas Academia ”The tag line under the name on this publisher’s page is “Freedom to research.” It might better say “Freedom to be ripped off.” 
  • Hindawi  .. This publisher has way too many journals than can be properly handled by one publisher, I think (…)

I do like funny posts, but only if it is clear that the post is intended to be funny. Like the one by Alan Dove PhD about JCBBR.

JCBBR is dedicated to increasing the depth of research across all areas of this subject.

Translation: we’re launching a new journal for research that can’t get published anyplace else.

The journal welcomes the submission of manuscripts that meet the general criteria of significance and scientific excellence in this subject area.

We’ll take pretty much any crap you excrete.

Hattip: Catherine Arnott Smith, PhD at the MedLib-L list.

  1. I Got the Wrong Request from the Wrong Journal to Review the Wrong Piece. The Wrong kind of Open Access Apparently, Something Wrong with this Inherently… (laikaspoetnik.wordpress.com)
  2. A peer-review phishing scam (blog.pita.si)
  3. Academic Spam and Open Access Publishing (blog.pokristensson.com)
  4. What’s wrong with Scholarly Publishing? New Journal Spam and “Open Access” (blogs.ch.cam.ac.uk)
  5. From the Inbox: Journal Spam (alandove.com)
  6. Beall’s List of Predatory, Open-Access Publishers. 2012 Edition (http://metadata.posterous.com)
  7. Silly Sunday #42 Open Access Week around the Globe (laikaspoetnik.wordpress.com)




Happy Anniversary Highlight HEALTH, ScienceRoll & Sterile Eye!

13 12 2011

Starting a blog is easy. But maintaining a blog costs time and effort. Especially when having a job/while studying (and having a private life as well).

This blog almost celebrates its 4th year (February 2012).

I’m happy to notice that many established (bio)medical & library blogs, that inspired me to start blogging, are still around.

Like one of the greatest medical blogs, CasesBlog by Dr Ves Dimov. And the medlib blogs The Search Principle blog by Dean Giustini and the Krafty Librarian by Michelle Kraft.

All these blogs are still going strong.

The same is true for the blog ScienceRoll by Bertalan Mesko (emphasis on health 2.0), that celebrated its 5th anniversary last month. That same month Sterile Eye (Life, death and surgery through a lens) celebrated its 4th year of existence.

This month Highlight Health (main author Walter Jessen) celebrates its 5th year anniversary.

And the nice thing is that Highlight Health celebrates this with prize pack giveaways.

There are 4 drawings. Each prize pack consist of the following:

All you have to do is to subscribe to the blog in the form of an email alert. People, like me, who are already subscribers are also eligible to participate in the drawings. (see this post for all info)

With so many ’golden oldies’ around, I wonder about you, my audience. Do you blog? And if you do, for how long? Please tell me in the poll below.

If you are a (bio)medical, library or science blogger (blogging in English), I would appreciate if you could fill in this spreadsheet as well. You are free to edit the spreadsheet and add names of other bloggers as well.





Friday Foolery #45. What have you got in your head?

9 12 2011

What have you got in your head?

I hope it is not Barley, Chilli,  Hemp seeds, Candies, Black Rice,  Food for canaries,  Brain sandwich, Sugar or Hay. (No, are you nuts?)

But these foods do make beautiful, sometimes even tasty-looking “brains”.

The composition below is from the project “What have you got in your head?” (series 2, 2010) by the Italian Artist Sara Asnaghi. As you might have guessed she sculptured the human brains with different  foods. Each brain is 17 cm by 12 cm.

Watch the higher quality individual art works/photos at Behance Network (The Creative Professional Platform). [Creative Commons, Attribution-NonCommercial]





Experience versus Evidence [1]. Opioid Therapy for Rheumatoid Arthritis Pain.

5 12 2011

ResearchBlogging.orgRheumatoid arthritis (RA) is a chronic auto-immune disease, which causes inflammation of the joints that eventually leads to progressive joint destruction and deformity. Patients have swollen, stiff and painful joints.  The main aim of treatment is to reduce swelling  and inflammation, to alleviate pain and stiffness and to maintain normal joint function. While there is no cure, it is important to properly manage pain.

The mainstays of therapy in RA are disease-modifying anti-rheumatic drugs (DMARDs) and non-steroidal anti-inflammatory drugs (NSAIDs). These drugs primarily target inflammation. However, since inflammation is not the only factor that causes pain in RA, patients may not be (fully) responsive to treatment with these medications.
Opioids are another class of pain-relieving substance (analgesics). They are frequently used in RA, but their role in chronic cancer pain, including RA, is not firmly established.

A recent Cochrane Systematic Review [1] assessed the beneficial and harmful effects of opioids in RA.

Eleven studies (672 participants) were included in the review.

Four studies only assessed the efficacy of  single doses of different analgesics, often given on consecutive days. In each study opioids reduced pain (a bit) more than placebo. There were no differences in effectiveness between the opioids.

Seven studies between 1-6 weeks in duration assessed 6 different oral opioids either alone or combined with non-opioid analgesics.
The only strong opioid investigated was controlled-release morphine sulphate, in a single study with 20 participants.
Six studies compared an opioid (often combined with an non-opioid analgesic) to placebo. Opioids were slightly better than placebo in improving patient reported global impression of clinical change (PGIC)  (3 studies, 324 participants: relative risk (RR) 1.44, 95% CI 1.03 to 2.03), but did not lower the  number of withdrawals due to inadequate analgesia in 4 studies.
Notably none of the 11 studies reported the primary and probably more clinical relevant outcome “proportion of participants reporting ≥ 30% pain relief”.

On the other hand adverse events (most commonly nausea, vomiting, dizziness and constipation) were more frequent in patients receiving opioids compared to placebo (4 studies, 371 participants: odds ratio 3.90, 95% CI 2.31 to 6.56). Withdrawal due to adverse events was  non-significantly higher in the opioid-treated group.

Comparing opioids to other analgesics instead of placebos seems more relevant. Among the 11 studies, only 1 study compared an opioid (codeine with paracetamol) to an NSAID (diclofenac). This study found no difference in efficacy or safety between the two treatments.

The 11 included studies were very heterogeneous (i.e. different opioid studied, with or without concurrent use of non-opioid analgesics, different outcomes measured) and the risk of bias was generally high. Furthermore, most studies were published before 2000 (less optimal treatment of RA).

The authors therefore conclude:

In light of this, the quantitative findings of this review must be interpreted with great caution. At best, there is weak evidence in favour of the efficacy of opioids for the treatment of pain in patients with RA but, as no study was longer than six weeks in duration, no reliable conclusions can be drawn regarding the efficacy or safety of opioids in the longer term.

This was the evidence, now the opinion.

I found this Cochrane Review via an EvidenceUpdates email alert from the BMJ Group and McMaster PLUS.

EvidenceUpdate alerts are meant to “provide you with access to current best evidence from research, tailored to your own health care interests, to support evidence-based clinical decisions. (…) All citations are pre-rated for quality by research staff, then rated for clinical relevance and interest by at least 3 members of a worldwide panel of practicing physicians”

I usually don’t care about the rating, because it is mostly 5-6 on a scale of 7. This was also true for the current SR.

There is a more detailed rating available (when clicking the link, free registration required). Usually, the newsworthiness of SR’s scores relatively low. (because it summarizes ‘old’ studies?). Personally I would think that the relevance and newsworthiness would be higher for the special interest group, pain.

But the comment of the first of the 3 clinical raters was most revealing:

He/she comments:

As a Palliative care physician and general internist, I have had excellent results using low potency opiates for RA and OA pain. The palliative care literature is significantly more supportive of this approach vs. the Cochrane review.

Thus personal experience wins from evidence?* How did this palliative care physician assess effectiveness? Just give a single dose of an opiate? How did he rate the effectiveness of the opioids? Did he/she compare it to placebo or NSAID (did he compare it at all?), did he/she measure adverse effects?

And what is “The palliative care literature”  the commenter is referring to? Apparently not this Cochrane Review. Apparently not the 11 controlled trials included in the Cochrane review. Apparently not the several other Cochrane reviews on use of opioids for non-chronic cancer pain, and not the guidelines, syntheses and synopsis I found via the TRIP-database. All conclude that using opioids to treat non-cancer chronic pain is supported by very limited evidence, that adverse effects are common and that long-term use may lead to opioid addiction.

I’m sorry to note that although the alerting service is great as an alert, such personal ratings are not very helpful for interpreting and *true* rating of the evidence.

I would rather prefer a truly objective, structured critical appraisal like this one on a similar topic by DARE (“Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects”)  and/or an objective piece that puts the new data into clinical perspective.

*Just to be clear, the own expertise and opinions of experts are also important in decision making. Rightly, Sackett [2] emphasized that good doctors use both individual clinical expertise and the best available external evidence. However, that doesn’t mean that one personal opinion and/or preference replaces all the existing evidence.

References 

  1. Whittle SL, Richards BL, Husni E, & Buchbinder R (2011). Opioid therapy for treating rheumatoid arthritis pain. Cochrane database of systematic reviews (Online), 11 PMID: 22071805
  2. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, & Richardson WS (1996). Evidence based medicine: what it is and what it isn’t. BMJ (Clinical research ed.), 312 (7023), 71-2 PMID: 8555924
Enhanced by Zemanta




Friday Foolery #44. The Shortest Abstract Ever.

2 12 2011

This is the shortest abstract I’ve ever seen:

“probably not”

With many thanks to Michelynn McKnight, PhD, AHIP, Associate Professor, School of Library and Information Science, Louisiana State University, who put it on the MEDLIB-L listserv, saying :  “Not exactly structured …. but a great laugh!”

According to Zemanta (articles related to this post) Future Twit also blogged about it.

Related articles





Things to Keep in Mind when Searching OVID MEDLINE instead of PubMed

25 11 2011

When I search extensively for systematic reviews I prefer OVID MEDLINE to PubMed for several reasons. Among them, it is easier to build a systematic search in OVID, the search history has a more structured format that is easy to edit, the search features are more advanced giving you more control over the search and translation of the a search to OVID EMBASE, PSYCHINFO and the Cochrane Library is “peanuts”, relatively speaking.

However, there are at least two things to keep in mind when searching OVID MEDLINE instead of PubMed.

1. You may miss publications, most notably recent papers.

PubMed doesn’t only provide access to MEDLINE, but also contains some other citations, including in-process citations which provide a record for an article before it is indexed with MeSH and added to MEDLINE.

As previously mentioned, I once missed a crucial RCT that was available in PubMed, but not yet available in OVID/MEDLINE.

A few weeks ago one of my clients said that she found 3 important papers with a simple PubMed search that were not retrieved by my exhaustive OVID MEDLINE (Doh!).
All articles were recent ones [Epub ahead of print, PubMed - as supplied by publisher]. I checked that these articles were indeed not yet included in OVID MEDLINE, and they weren’t.

As said, PubMed doesn’t have all search features of OVID MEDLINE and I felt a certain reluctance to make a completely new exhaustive search in PubMed. I would probably retrieve many irrelevant papers which I had tried to avoid by searching OVID*. I therefore decided to roughly translate the OVID search using textwords only (the missed articles had no MESH attached). It was a matter of copy-pasting the single textwords from the OVID MEDLINE search (and omitting adjacency operators) and adding the command [tiab], which means that terms are searched as textwords (in title and abstract) in PubMed (#2, only part of the long search string is shown).

To see whether all articles missed in OVID were in the non-MEDLINE set, I added the command: NOT MEDLINE[sb] (#3). Of the 332 records (#2), 28 belonged to the non-MEDLINE subset. All 3 relevant articles, not found in OVID MEDLINE, were in this set.

In total, there were 15 unique records not present in the OVID MEDLINE and EMBASE search. This additional search in PubMed was certainly worth the effort as it yielded more than 3 new relevant papers. (Apparently there was a boom in relevant papers on the topic, recently)

In conclusion, when doing an exhaustive search in OVID MEDLINE it is worth doing an additional search in PubMed to find the non-MEDLINE papers. Regularly these are very relevant papers that you wouldn’t like to have missed. Dependent on your aim you can suffice with a simpler, broader search for only textwords and limit by using NOT MEDLINE[sb].**

From now on, I will always include this PubMed step in my exhaustive searches. 

2. OVID MEDLINE contains duplicate records

I use Reference Manager to deduplicate the records retrieved from all databases  and I share the final database with my client. I keep track of the number of hits in each database and of the number of duplicates to facilitate the reporting of the search procedure later on (using the PRISM flowchart, see above). During this procedure, I noticed that I always got LESS records in Reference Manager when I imported records from OVID MEDLINE, but not when I imported records from the other databases. Thus it appears that OVID MEDLINE contains duplicate records.

For me it was just a fact that there were duplicate records in OVID MEDLINE. But others were surprised to hear this.

Where everyone just wrote down the number of total number hits in OVID MEDLINE, I always used the number of hits after deduplication in Reference Manager. But this is a quite a detour and not easy to explain in the PRISM-flowchart.

I wondered whether this deduplication could be done in OVID MEDLINE directly. I knew you cold deduplicate a multifile search, but would it also be possible to deduplicate a set from one database only? According to OVID help there should be a button somewhere, but I couldn’t find it (curious if you can).

Googling I found another OVID manual saying :

..dedup n = Removes duplicate records from multifile search results. For example, ..dedup 5 removes duplicate records from the multifile results set numbered 5.

Although the manual only talked about “multifile searches”, I tried the comment (..dedup 34) on the final search set (34) in OVID MEDLINE, and voilà, 21 duplicates were found (exactly the same number as removed by Reference manager)

The duplicates had the same PubMed ID (PMID, the .an. command in OVID), and were identical or almost identical.

Differences that I noticed were minimal changes in the MeSH (i.e. one or more MeSH  and/or subheadings changed) and changes in journal format (abbreviation used instead of full title).

Why are these duplicates present in OVID MEDLINE and not in PubMed?

These are the details of the PMID 20846254 in OVID (2 records) and in PubMed (1 record)

The Electronic Date of Publication (PHST)  was September 16th 2010. 2 days later the record was included in PubMed , but MeSH were added 3 months later ((MHDA: 2011/02/12). Around this date records are also entered in OVID MEDLINE. The only difference between the 2 records in OVID MEDLINE is that one record appears to be revised at 2011-10-13, whereas the other is not.

The duplicate records of 18231698 have again the same creation date (20080527) and entry date (20081203), but one is revised 2110-20-09 and updated 2010-12-14, while the other is revised 2011-08-18 and updated 2011-08-19 (thus almost one year later).

Possibly PubMed changes some records, instantaneously replacing the old ones, but OVID only includes the new PubMed records during MEDLINE-updates and doesn’t delete the old version.

Anyway, wouldn’t it be a good thing if OVID deduplicated its MEDLINE records on a daily basis or would replace the old ones when loading  new records from MEDLINE?

In the meantime, I would recommend to apply the deduplicate command yourself to get the exact number of unique records retrieved by your search in OVID MEDLINE.

*mostly because PubMed doesn’t have an adjacency-operator.
** Of course, only if you have already an extensive OVID MEDLINE search.





Silly Sunday #43 Know Your Numbers

20 11 2011

As I touched upon in Grand Rounds 8.5 the Mayo Clinic Center held the 3rd Social Media’s Health Care Social Media Summit a few weeks ago. Lots of good information and resources were shared, including the video below. The video has already gone viral (it has been viewed appr. 24,000 times), but most important is that its message gets viral.

The song is a parody of 867-5309/Jenny, produced by the Mayo Clinic Center* to promote healthy heart awareness, especially among women:

Heart disease is the number one killer of men and women, but most women aren’t aware of this.

You need to know your numbers, don’t let them get too highblood pressure, lipids and BMI

I love it & remember, know your numbers!

Go to http://knowyournumbers.me/ to calculate your heart risk (BMI and LDL-cholesterol) and see how you can lower it.

You can become a fan of Mayo Clinic at Facebook:
http://www.facebook.com/MayoClinic

* For this purpose, the band of Ron Menaker, the administrator for the Mayo Clinic Division of Cardiovascular Diseases, was renamed to “Tommy and the Heartbeats” (see The  Making of  Know Your Numbers) .

Hattip: Scott Hensley (Facebook)





Friday Foolery #42 So You Think You Can Dance Your PhD Thesis?

5 11 2011

It’s hard to explain your research to non-scientists. My PhD defense was preceded by a slide show (yes, that was once-upon-a-time that we didn’t use Powerpoint). It was the only part the public could follow a bit. But it is too long, static and detailed.

That cannot be said of these videos, where PhD’s from all over the world interpret their graduate research in dance form.

The videos below are the winners of the 2011 edition of the Dance your PhD contest. For the 4th year, this contest is organized by Gonzolabs & Science. See http://gonzolabs.org/dance/

There are 4 categories—chemistry, physics, biology, and social sciences

The overall winner of 2011 was Joel Miller (category physics), a biomedical engineer at the University of Western Australia in Perth. Miller apparently compensated his poor dancing skills and the lack of a video by applying stop-motion animation (stringing together about 2,200 photos to make it look as though his “actors” were dancing). His video shows the creation of titanium  alloys that are both strong and flexible enough for long-lasting hip replacements.
I love the song by the way. It fits perfectly to the dance scene.

You can see all winning videos here and all 2011 (this years) PhD videos here. You can also check out the 2010 and the 2009 PhD dances.

The other winners of 2011 were  FoSheng Hsu (chemistry category) who guides viewers through the entire sequence of steps required for x-ray crystallography,  Emma Ware (social science) who studies the traditional ‘stimulus-release’ model of social interaction using pigeon courtship (a beautiful pas a deux) and Edric Kai Wei Tan (biology) with the funny dance about Smell mediated response to relatedness of potential mates, simply put “fruit fly sex”.

Being Dutch, I would like to close with the Dutch winner of the biology category in 2010, Maartje Cathelijne de Jong who dances her PhD, “The influence of previous experiences on visual awareness.”





Grand Rounds Vol 8 nr 5: Data, Information & Communication

26 10 2011

Welcome to the Grand Rounds, the weekly summary of the best health blog posts on the Internet. I am pleased to host the Grand Rounds for the second time. The first time, 2 years ago, was theme-less, but during the round we took a trip around the library. Because, for those who don’t know me, after years of biomedical research I became a medical librarian. This also explains my choice for the current theme:

DATA, INFORMATION & COMMUNICATION

The theme is meant to be broad. According to Wikipedia:

Information in its most restricted technical sense is a message (utterance or expression) or collection of messages that consists of an ordered sequence of symbols, or it is the meaning that can be interpreted from such a message or collection of messages. Information can be recorded or transmitted (…) as signs, or conveyed as signals by waves. Information is any kind of event that affects the state of a dynamic system. (…) Moreover, the concept of information is closely related to notions of … communication.. dataknowledge, meaning, .. perception. .. and especially entropy.

I am pleased that there were plenty submissions on the topic. I love the creative way the bloggers used the theme “information”. In line with the theme the information will be brought to you according to the Rule of Entropy, seemingly chaotic. Still all information is meaningful and often a pleasure to read. Please Enjoy!

INDIA, WISDOM & IMAGESIMAGING

From: IBN-live (India): Book News: “Kama Sutra is about sexual & social relations”

IMAGES are a great way to tell information, especially if you don’t understand the language. The picture above is from the Kama Sutra, an ancient Indian Hindu work on human sexual behavior in Sanskrit literature. Did you know the original Kama Sutra is not all about sex and does not have any pictures? Only words, no graphic. And sadly, as a text, it isn’t widely read.

Yes, we start our trip where it ended last week, in INDIA

Our host of last week, Sumer Sethi of Sumer’s Radiology Site, shows very clear (MRI)-images of partially recanalized internal jugular vein thrombosis, in a patient with MS, possibly supporting the theory that MS is a result of chronic venous insufficiency. As readers of this blog know Laika is not impressed by n=1 data, although it may be a good starting point. However, Sumer underpins this link with a paper in J Neurol Neurosurg Psychiatry 2009. Still, a quick look at the citing papers shows many new studies don’t confirm the association of MS with cerebrospinal venous insufficiency…

Another great radiologist, also from India, isVijay Sadasivam (@scanman). No recent posts, but at Scanman’s Casebook you will find an archive of interesting radiological cases, in the form of case reports.

The quite tech savvy surgeon Dr. Dheeraj (aka Techknowdoc) explores the alternatives to the invasive and uncomfortable colonoscopy procedure at Techknowdoc’s Surgical Adventures! This post is a short illustrated guide, visualizing the differences between regular colonoscopy, capsule endoscopy and Virtual Colonoscopy. It is not hard to imagine which approach people would prefer.

Pranab (aka Skepticdoctor) makes an urgent appeal to fellow Indians to help Amit Gupta and other Indian people to get a bone marrow transplant when they need one. Amit has Acute Leukemia, but South Asians are very poorly represented in bone marrow registries, so his odds of getting a match off the registries in the US are slim. The chances are even worse for the less well-off Indians. Read at Scepticemia how you can help. For Amit, for India, for you, or worse, someone you love more than yourself….

Dr. Jen Gunter ridicules Cosmo’s to-go version of the Kama Sutra in a short series! For the “sex positions of the days” are just an offensive alliteration and woeful ignorance of female anatomy… Looking up medical information is the 3rd most common on-line activity. While there are good sites with great information that can help people be empowered about their health, there are also tons of terrible sites marred by bias and rife with the stench of snake oil. In an other post at Dr. Jen Gunter (wielding the lasso of truth) Jen reveals 10 red flags that will help you separate the wisdom from the woo.

THE POWER OF WORDS, MUSIC AND VISUAL ARTS

http://www.flickr.com/photos/isfullofcrap/5147100521/

Yes, a picture is worth a thousand words. And this is also true for other audiovisual arts. 

Yet, some Medical Bloggers master the art of storytelling, they convey of events in words, images and sounds. And here, words have the same powerful strength. Often these posts of these storytellers are about communication and they know how to communicate that.

One of the master storytellers is Bongi, a general surgeon from South Africa. He submitted the post die taal (that language), which is clearly about communication but in a language (“Afrikaans”), that I can understand, but many of you don’t. Therefore I choose another post at Other Things Amanzi, which is also about communication: “It’s all in the detail”

Another great storyteller, and the winner of the best literary medical blog category of Medgadget contest in 2009 and 2010 is StorytellERdoc. In the beautiful post The Reminder – EKG #6, he tells us how the 6th abnormal EKG in a presentation of one of the residents, brought back memories to the technician who made that EKG: “There is something more important about this EKG than it’s tracing, I began” ….

Robbo (Andrew Roberts) is a pharmacist from one of the most remote parts of Australia working full time in Aboriginal Health. His blog BitingTheDust often covers topics like aboriginal art and pharmacy. There is also a category “information-resources”. His latest post in this category explains how condoms are made and how they work. A video goes with it.

Øystein of  The Sterile Eye (Life, death and surgery through a lens) uses photos throughout his blog. His latest post is about a brochure “LEICA – Fotografie in der Medizin” (Photography in Medicine) that was published by Leitz in 1961.

Another blogger, unique in its kind, “raps” his stories. Yes I’m talking about Zubin, better known as ZDoggMD. Watch how he and his mates colleagues rap “Doctors Today!” where he ”informs” folks of what it’s like to actually practice primary care medicine on the front lines. Want to know more about this medical rapper, then listen to this radio interview with a med-student run radio (RadioRounds). It’s about using video to “inform” patients and healthcare providers about health-related issues in a humorous way.

Movies are also a good way to “tell a story” and pass information. Ramona Bates reviews the Lifetime’s Movie “Five” at her blog Suture for a Living. Five is an anthology of five short very emotional (but not sentimental) films exploring the impact of breast cancer on people’s lives.

We have had pictures, music, videos and movies as data carriers. But here is a post that is based on the good old book. Dr. Deborah Serani (who has a blog of her own: Dr. Deb: Psychological Perspectives) submits a review from PsychCentral about her new book “Living with Depression.” My first intuitive response: how can a psychologist or psychoanalyst write about “living with“. But it seems that Deborah Serani has faced a lifelong struggle with depression herself. This memoir/self help book seems a great resource for anyone in the health field looking for information about mood disorders, treatments and recommendations. The review makes me want to read this book.

SOCIAL MEDIA & MOBILE APPS

http://www.flickr.com/photos/verbeeldingskr8/4507350257/

What about social media as a tool for medical communication and a source of information?

At Diabetes Mine Allison B. and Amy Tenderich review numerous new mobile apps for managing diabetes. Their reviews “Diabetes? There’s An App For That“ and “Glooko: iPhone Diabetes Logging Made Super-Easy” may help to choose diabetes patients among the bevvy of diabetes apps.

Twitter is seen as offering more noise than signal, but there’s valid medical data that can be uncovered. Ryan DuBosar at the ACP internist blog highlights how a researcher uses Twitter to track attitudes about vaccination and how they correlate with vaccination rates. The study adds to a growing body of evidence that social networking can be used to track diseases and other natural disasters that affect public health.

Hot from the press, I can’t resist to include a post from the web 2.0 pioneer Dr. Ves at CasesBlog. Ves Dimov usually writes many short posts, but today he explains Social media in Medicine in depth and guides you “How to be a Twitter superstar and help your patients and your practice”. According to his interesting concept two Cycles, the cycle of Patient Education and the Cycle of Online Information and Physician Education, work together as two interlocking cogwheels.

Mayo Clinic started using social media for communication with patients well before all the recent hype and it organized tweetcamps back in 2009. David Harlow made the pilgrimage to Rochester, MN and spoke at the Mayo Clinic Center for Social Media’s Health Care Social Media Summit last week. According to David “A ton of information was presented, through traditional channels and through some multimedia demos as well”. He shares conference highlights in this post at HealthBlawg, like “It is impossible to transplant a successful program from one location to another without taking into account myriad local conditions”. And “health care providers will have to do more with less”. Therefore e-Patient Dave suggests in his closing keynote to “Let Patients Help”.

Nicholas Fogelson of Academic OB/GYN notes that an operating room without incentives is very expensive. He proposes to install a cheap digital toteboard in every operating room in the USA, that would read how many dollars have been spent on that case at that moment. The idea is that surgeons who know exactly what they are spending, would compete to spend less wherever they could.

According to Bryan Vartabedian the social and technological innovations cause doctors to slowly change from analog physicians to digital physicians. He mentions 6 differences between these doctors. The first is that the information consumption of the digital physician is web-based, while the analog doctor consumes information through paper books and journals, often saying curious things like, “I like the smell of paper” or “I’ve gotta be able to hold it.” By the way, Bryan’s blog 33 Charts is all about social media and medicine.

Blogging doctors are digital doctors per definition, but that doesn’t mean they don’t want to discuss things and see each other in real life. Dr. Val of Better Health and cofounder of this Grand Rounds announces a blog conference in Los Angeles, the Blog World Expo, on November 4th, 2011. Her talk is about “physicians engaging online in social health”, but she is actually hoping that many members of the medical blogging community will be out there IRL! At her blog you can get discount tickets.

The online presence of doctors at social media places can have serious drawbacks. The post of Anne Marie Cunningham about derogatory and cynical humour as displayed by medical personnel at Twitter and Facebook has made it to the Daily Telegraph, other UK newspaper, and to my blog…. This post at Wishful thinking in medical education is a must read for healthcare providers embracing social media.

Many physicians have an online presence, but do they really use social media for decision making, wonders Chris Nickson. From his post and the ensuing reactions at Life in the Fast Lane it appears that tools like Twitter and the comments sections on blogs enable a constant, ongoing dialogue with emergency physicians and critical care experts around the world regarding puzzling clinical issues. Rarely, however, there is a direct ‘tweet’ for clinical help. Rather Twitter contributes to the serendipitously finding of relevant and significant information.

Perhaps direct clinical questions are not asked because Twitter (and Facebook to some extent) are open social media. Bertalan Mesko of ScienceRoll mentions that some French doctors actually perform case presentations on Google+, taking advantage of the very simple privacy settings of Google+. They upload information about the case, discuss it with other peers and get to a final diagnosis.

E-Patient Dave announced a seven hour event about information transfer during transitions of care. This event was webcasted, tweeted and discussed on Google+. (also see Brian Ahier’s post about it on Government Health IT). Dave gives some examples that highlight that without reliable information transition, the care transition can become dangerous. Yes, good IT can help.

DATA, DATABASES, OPEN ACCESS, EBM

http://www.flickr.com/photos/verbeeldingskr8/4029292954/

We now arrive at a clinical librarian topic, medical information via databases, journals and the role of EBM.

The first post bridges this and the previous topic. Jon Brassey is co-founder of  the TRIP-database, a clinical search tool designed to rapidly identify the highest quality clinical evidence for clinical practice. At his blog Liberating the Literature he expresses his view that search is -at best- a partial solution. He is passionate about answering clinician’s questions and would rather see an answer machine than a search engine. Jon is very tempted to allow users to upload their own Q&As, thereby creating an open repository of clinical Q&As. I am more skeptical, because this kind of EBM sharing might be at the expense of the quality of evidence.

What do you think? Can social media and EBM reinforce each other or not? Please tweet your ideas to Anabel Bentley (@doctorblogs at Twitter) who is giving a talk at Evidence 2011 (#ev2011) tomorrow on social media & EBM and asks for your input. You might also want to read my older post about The Web 2.0-EBM Medicine split.

Dean Giustini reviews PubMed Health at The Search Principle Blog. Dean describes PubMed Health as follows. It is as a consumer version of PubMed – a metasearch tool that gathers evidence from Cochrane Collaboration, Nice and other EBM sources to see clinical studies and “what works” in human health. One major benefit of PubMed Health is that any search performed on PubMed Health also runs in PubMed.” Sounds like worth trying.

The invitation to join the editorial board of a relatively new online, open access journal, without receiving any compensation triggered Skeptic Scalpel to ponder about the tangible benefits of open access publishers (coined as “predatory open access” by a commenter) and about how many journals are really needed? Who has the time or interest to read 25 journals on a relatively specialized topic? And what about the quality of the articles in all these journals?

Indeed as The Krafty Librarian explains  the “good guys” (open access) are making just as much profit as the “bad guys.”  They both are for profit. Open Access is not the panacea that many think it is.

Tasha Stanton of Body in Mind asks the intriguing question what to do if systematic reviews on the same topic don’t all give us the same conclusions, whereas you would expect they would collate the same evidence. Tasha finds this disconcerting as for some conditions this could take ages before we could ‘trust’ the evidence. In the example discussed here an Umbrella review was helpful in assessing the evidence. Also the quality of systematic reviews is improving.

SCREENING & DIAGNOSIS. BALANCING BENEFITS & HARMS. 

From: http://www.naturalnews.com/025768_radiation_cancer_mammograms.html as seen at Science Based Medicine

Many people think screening is always a good thing and will prevent or cure a disease. But not every test is a good test and often there are both harms and benefits. It is difficult for patients to understand the true value of tests. 

Margaret Polaneczky, MD was touched by a beautiful essay in the NY Times written by a mother of a child born with Tay Sachs disease. While the mother in her loved the essay, the doctor in her cringed, because a single paragraph about the mother’s experience with prenatal screening had the potential to misinform and even frighten readers. Margaret writes a bit of a primer on Tay Sachs screening at the Blog That Ate Manhattan, mainly to set realistic expectations about what prenatal testing can and cannot accomplish.

David Williams at the Health Business Blog reasons that the US Preventive Services Task Force (USPTF) recommendations against routine use of the PSA blood test in healthy men should not have been delayed because of the the firestorm of controversy created by the 2009 screening mammography guidelines… Because uh-oh well, PSA testing is different (and David is right)…  It’s all about what kind of info we can expect from screening and where it leads us.

This month is breast cancer awareness month, meant to highlight issues of breast cancer and try to call attention to new discoveries about breast cancer. Personally I have mixed feelings about the pink ribbon exploitation of this month”, but David Gorky at Science Based Medicine points at a worse misuse: quacks seize the opportunity to spread their message against science-based modalities for the detection and treatment of breast cancer and to promote their “alternative” methods. (see Fig. above).

BIOMEDICINE, BRAINS AND THE PROCESSING OF INFORMATION

http://www.flickr.com/photos/caseorganic/3675792814/ [CC]

Dr Shock MD PhD reviews a Dutch trial that shows that availability bias contributes to diagnostic errors made by physicians. Availability bias means that a disease comes more easily to the mind of a doctor who diagnoses this disease more often. This study also suggests that analytical or reflective reasoning may help to counteract this bias.

In an intriguing post counseling psychologist Will Meek, PhD covers some of the recent research on two information processing systems as identified by Daniel Kahneman: Intuition and Reasoning. A simple experiment confirms (in my case) that we use intuition for most of the day, and occasionally use reasoning to answer more complex problems. Some people may also frame this as “head vs heart”. Both systems have their pros and cons and both are needed to make good decisions. Otherwise common problems can arise.

David Bradley of ScienceBase discusses recent research by Gallant and colleagues who were able to reconstruct a video image presented to a subject in a functional MRI machine. David dreams of uploading our dreams to Youtube and of developing a mind-machine interface to allow people with severe disabilities to communicate their thoughts and control a computer or equipment. But David is more of a scientist than a dreamer and he interviews Gallant to find out more about the validity of the technique.

Computational Biologist Walter Jessen highlights “National Biomedical Research Day” at Highlight HEALTH. “National Biomedical Research Day” was proclaimed by Bill Clinton in 1993 on the 160th anniversary of Nobel’s birth. This day celebrates the central role of biomedical research  in improving human health and longevity.

MISINFORMATION, WRONG INFORMATION AND LACK OF INFORMATION

http://www.flickr.com/photos/truthout/3901813960/
This image was paired with the story: Insurers Shun Those Taking Certain Meds

Philip Hickey at Behaviorism and Mental Health discusses homosexuality. Philip: “homosexuality is a complex phenomenon which defies simplistic explanations. Unfortunately in this field valid information and communication often take a back seat to bigotry and prejudice.”

In his post ”Want go Dutch…or German…or French?” at HUB’s LIST of medical fun facts Herbert Mathewson, MD argues that “Before trying to copy other nation’s health care systems we should probably actually learn about them.” The outcomes of the Dutch switch from a system of mandatory social insurance administered by nonprofit sick funds to mandatory basic insurance that citizens had to buy from private insurance companies (“managed competition”) are appalling! I can imagine that the idea that the Dutch reforms provide a successful model for U.S. Medicare seems bizarre. (Herbert’s post is based on a NEJM article “Sobering Lessons from the Netherlands”).

Henry Stern of InsureBlog notes that as far as RomneyCare© (Massachusetts health care reform) is concerned it’s not so much lack of information per se that’s the problem. It’s information that’s wrong that gets you in trouble.

Robert Centor of Medrants simply submitted one sentence:
“I am a physician, not a provider, and Groopman agrees. - http://www.medrants.com/archives/6505″
This distinction between physicians and providers is similar to the distinction between consumers and patients, and I agree.

Rich Fogoros (DrRich) of The Covert Rationing Blog discusses recent article in the New York Times about whether nurses with a doctorate degree ought to be addressed as “doctor.” Most doctors think calling a nurse “doctor” is not appropriate and confusing for patients.
A medical student running the blog The Reflex Hammer agrees: medical students with a doctoral degree don’t introduce themselves as “Doctor” to a patient either, don’t they?
Dr Rich, an old hand, thinks otherwise. While it is indeed comforting that doctors should be so concerned about patients knowing everything they’re supposed to know, the fact (according to dr. Rich) is that the doctor-nurse controversy is a distraction.

INFORMATION YOU NEED


http://www.flickr.com/photos/nirak/1386793065/
credit: mattahan.deviantart.com/
Note: this is a librarian!!

And of course you always hope that you find the information you need or that you can inform people the right way.

Medaholic wonders whether you still would be a medical doctor if you knew that it didn’t pay as much? What sorts of information would help you determine whether this is a career worth pursuing?

The post, by Chris Langston, at the John A. Hartford Foundation blog, Health AGEnda details how interested health professionals can get information about how to apply for a new fellowship with the Center for Medicare & Medicaid Innovations office, and urges health professionals interested in improving health care for older adults to apply.

Hospital antimicrobial stewardship programs are prompting more appropriate prescribing of antibiotics, leading to improved patient care, less microbial resistance and lower costs, three studies show. The trick is how to convey this information so hospitals will implement these programs, as only one-third of U.S. facilities currently do. Read more at ACP Hospitalist, in the second contribution of Ryan DuBosar to this round.

We all know that adherence to prescriptions is a problem. But will the Star Ratings system increase adherence? The big question, according to Georg van Antwerp, author of Enabling Healthy Decisionsis whether consumers care about Star Ratings or just focus on lowest price point and access to pharmacies or specific medications.

Louise of the Colorado Health Insurer Insider summarizes her submission quite aptly: “Our submission is about the new Health Insurance Exchanges that will be starting here in the US soon. This post discusses how consumers will get INFORMATION about the health plans through the exchanges. Currently, consumers get their information through health insurance brokers or directly through the insurance carrier. If there are people to answer questions for consumers with the exchanges, how will the plans be more or less expensive”

The post that Reflex Hammer submitted (the one above was just picked by me) concerns informing young children about vegetables. A few weeks ago he and a classmate were invited to give a presentation to 1st graders at an inner-city school. Wishing to combat obesity, they developed a lesson plan about vegetables. They were heartened by how much the adorable kids already knew about vegetables and how enthusiastic they became about eating their greens. An adorable initiative and a great post to end this Grand Rounds, since it illustrates the importance of doctors who enjoy to take their time to inform people.

I just want to mention one other post, by Mike Cadogan at Life at the fast Lane. Mike doesn’t blog a lot lately, because he is preparing presentations for an important Emergency Medicine meeting. But Mike does share some of this journey with us in The 11 Phases Of Grief  Presentation Preparation. Reading these 11 stages, the similarities between writing a lecture and writing for Grand Rounds struck me. Except that beer had to be replaced by wine….

Mike is in stage 7-9, I am in stage 10-11. Stage 11 is Evaluation: What will I do different next time? First, I won’t go for two blog carnivals at the same time, I won’t plan a Grand Round when I’m away for the weekend* (I just need a lot of time) and I should refrain from adding posts that weren’t even submitted….

Will you remind me next time?

I hope that you enjoyed this Grand Rounds and that it wasn’t too much information. I enjoyed reading and compiling all our posts!

Related articles








Follow

Get every new post delivered to your Inbox.

Join 41 other followers